Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Statins and the risk of dementia.

Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA.

Lancet. 2000 Nov 11;356(9242):1627-31. Erratum in: Lancet 2001 Feb 17;357(9255):562.

PMID:
11089820
2.

Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis.

Jick SS, Choi H, Li L, McInnes IB, Sattar N.

Ann Rheum Dis. 2009 Apr;68(4):546-51. doi: 10.1136/ard.2008.091967. Epub 2008 Jul 28.

PMID:
18662929
3.
4.

HMG-CoA reductase inhibitors and the risk of fractures.

Meier CR, Schlienger RG, Kraenzlin ME, Schlegel B, Jick H.

JAMA. 2000 Jun 28;283(24):3205-10.

PMID:
10866867
5.

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

Rockwood K, Kirkland S, Hogan DB, MacKnight C, Merry H, Verreault R, Wolfson C, McDowell I.

Arch Neurol. 2002 Feb;59(2):223-7.

PMID:
11843693
6.

Lipid-lowering agents and the risk of cognitive impairment that does not meet criteria for dementia, in relation to apolipoprotein E status.

Rockwood K, Howlett S, Fisk J, Darvesh S, Tuokko H, Hogan DB, Wolfson C, McDowell I.

Neuroepidemiology. 2007;29(3-4):201-7. Epub 2007 Nov 27.

PMID:
18043005
7.

Statin use and risk of first-time psoriasis diagnosis.

Brauchli YB, Jick SS, Meier CR.

J Am Acad Dermatol. 2011 Jul;65(1):77-83. doi: 10.1016/j.jaad.2010.05.039. Epub 2011 May 6.

PMID:
21529997
8.

Seizures in patients with Alzheimer's disease or vascular dementia: a population-based nested case-control analysis.

Imfeld P, Bodmer M, Schuerch M, Jick SS, Meier CR.

Epilepsia. 2013 Apr;54(4):700-7. doi: 10.1111/epi.12045. Epub 2012 Dec 6.

9.

HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients.

Wang PS, Solomon DH, Mogun H, Avorn J.

JAMA. 2000 Jun 28;283(24):3211-6.

PMID:
10866868
10.

Statin use and the risk of incident dementia: the Cardiovascular Health Study.

Rea TD, Breitner JC, Psaty BM, Fitzpatrick AL, Lopez OL, Newman AB, Hazzard WR, Zandi PP, Burke GL, Lyketsos CG, Bernick C, Kuller LH.

Arch Neurol. 2005 Jul;62(7):1047-51.

PMID:
16009757
11.

APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study.

Dufouil C, Richard F, Fiévet N, Dartigues JF, Ritchie K, Tzourio C, Amouyel P, Alpérovitch A.

Neurology. 2005 May 10;64(9):1531-8.

PMID:
15883313
12.

Risk of pneumonia in patients taking statins: population-based nested case-control study.

Vinogradova Y, Coupland C, Hippisley-Cox J.

Br J Gen Pract. 2011 Nov;61(592):e742-8. doi: 10.3399/bjgp11X606654.

13.

Statin use and risk of gallstone disease followed by cholecystectomy.

Bodmer M, Brauchli YB, Krähenbühl S, Jick SS, Meier CR.

JAMA. 2009 Nov 11;302(18):2001-7. doi: 10.1001/jama.2009.1601.

PMID:
19903921
14.

Hyperlipidaemia in paediatric patients: the role of lipid-lowering therapy in clinical practice.

Wierzbicki AS, Viljoen A.

Drug Saf. 2010 Feb 1;33(2):115-25. doi: 10.2165/11319490-000000000-00000. Review.

PMID:
20082538
15.

Statins and the risk of pneumonia: a population-based, nested case-control study.

Schlienger RG, Fedson DS, Jick SS, Jick H, Meier CR.

Pharmacotherapy. 2007 Mar;27(3):325-32.

PMID:
17316144
16.

The risk of dementia in relation to statins and other lipid lowering agents.

Rockwood K, Darvesh S.

Neurol Res. 2003 Sep;25(6):601-4. Review.

PMID:
14503013
17.

Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women.

Chan KA, Andrade SE, Boles M, Buist DS, Chase GA, Donahue JG, Goodman MJ, Gurwitz JH, LaCroix AZ, Platt R.

Lancet. 2000 Jun 24;355(9222):2185-8.

PMID:
10881890
18.
19.

Associations of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias.

Davies NM, Kehoe PG, Ben-Shlomo Y, Martin RM.

J Alzheimers Dis. 2011;26(4):699-708. doi: 10.3233/JAD-2011-110347.

PMID:
21709373
20.

Persistence with lipid-lowering therapy: influence of the type of lipid-lowering agent and drug benefit plan option in elderly patients.

Abughosh SM, Kogut SJ, Andrade SE, Larrat P, Gurwitz JH.

J Manag Care Pharm. 2004 Sep-Oct;10(5):404-11.

Items per page

Supplemental Content

Write to the Help Desk